16 Jan 2017 14:00
16 January 2017
FOR IMMEDIATE RELEASE
IXICO plc
("IXICO" or the "Company")
Annual Report and Accounts and Notice of AGM
IXICO PLC (Ticker: IXI), the brain health company, announces that its Annual Report and Accounts for the year ended 30 September 2016 and its Notice of Annual General Meeting (AGM) have been distributed to shareholders.
The AGM will be held at 9.30 am on Monday 30 January 2017 at the offices of FTI Consulting LLP, 200 Aldersgate Street, London, EC1A 4HD.
The Company's Annual Report and Accounts, which incorporates the Notice of AGM, are available on the Company's website http://ixico.com/investors/rns-announcements.
For further information please contact:
IXICO plc Derek Hill, Chief Executive Officer Susan Lowther, Chief Financial Officer |
Tel: +44 20 3763 7499 | |
Shore Capital (Nomad and Broker) Bidhi Bhoma / Edward Mansfield | Tel: +44 20 7408 4090 | |
FTI Consulting Limited (Investor Relations) Simon Conway/Mo Noonan/Matthew Moss | Tel: +44 20 3727 1000 |
|
About IXICO
IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions. In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes. In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.
The Company's brain health focus includes Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, behavioural health, child and adolescent mental health.
More information is available on www.ixico.com
Ixico (IXI)